Companies related to Neurodegenerative Diseases

Innovating Parkinson's Disease Care

We conduct world-class, collaborative, biological research and translate discoveries for the benefit of patients.

First-in-kind stem cell therapy to combat neurodegenerative diseases, giving back treatment perspective to millions

We are a biotech company focused on developing precision medicines for neurological and immunological diseases.

Advancing new technologies for brain health and neurostimulation

BioArctic focuses on developing disease modifying treatments for neurodegenerative diseases.

Our medical research will transform healthcare. We explore the full spectrum of disease to live life to the fullest.

Shifting the treatment paradigm for neurodegenerative disease towards precision medicine and disease prevention.

Creatively and diligently moving fast towards an effective treatment for people with ALS.

Research-driven biotechnology company developing epigenetic therapies for the treatment of chronic disease

Herantis Pharma Plc is a clinical-stage biotechnology company developing disease modifying therapies for Parkinson’s.

Innovating through embracing complexity

Developing innovative medicines for the treatment of neuropsychiatric and neurodegenerative diseases

Fast-track your pipeline with preclinical excellence. in vitro & in vivo research services since 1991.

Better Delivery for Better Care

Developing transformative gene therapies for patients suffering from severe rare diseases.

Preclinical studies in gut and gut brain for therapies of tomorrow

Analytics and training, saving lives, improving performance & early-detecting cognitive impairment

Neurotech & photomedicine

Leader in Alzheimer's disease research. Discovery and development of treatment for dementia. Targeting tau.

Right treatment. Right time. Real results.

Therapeutic Solutions for Neurodegeneration

Clinical-stage company developing novel therapeutics for diseases of high unmet need of the liver and nervous system

Pinpointing Dementia Early

Leading the way in lysosomal ion channel biology to address neurodegenerative diseases and metabolic storage disorders